AUTHORS
Mireya Mota, Harry J. Ashbaugh, MS2, Derek H. Janssens, PhD3
AFFILIATIONS
1 Van Andel Institute, Grand Rapids, United States
2 Van Andel Institute, Grand Rapids, United States
3 Van Andel Institute, Grand Rapids, Michigan, United States
ABSTRACT
Mutations in chromatin regulatory genes are among the most common initiating lesions in hematologic malignancies, yet how they alter chromatin to drive expansion of specific cell populations remains poorly understood. In myelodysplastic syndrome (MDS) chronic myelomonocytic leukemia and other myeloproliferative neoplasms, ASXL1 is among the most frequently mutated epigenetic regulators and has been implicated in altered stem-cell self-renewal and dysregulation of Polycomb-mediated gene repression. Polycomb-repressive chromatin is established by the coordinated activities of PRC2 and PRC1, which deposit H3K27me3 and H2AK119Ub, respectively. Existing genomic approaches profile only a single chromatin feature at a time or average across heterogeneous populations, preventing direct measurement of linked active and repressive chromatin states within disease-associated cells. As a result, how ASXL1 mutations affect Polycomb-mediated repression during hematopoiesis has remained unclear.
We developed CoCUT&Tag, a high-throughput platform that uses differentially barcoded Tn5 transposases to simultaneously profile multiple chromatin proteins and unambiguously resolve sites of linked chromatin-protein co-occupancy on individual DNA molecules in single cells. As a first step, we profiled H3K4 methylation together with H3K27me3 to map linked bivalent chromatin during normal human hematopoiesis. We found that bivalency increases during B-cell differentiation and frequently marks developmental genes that remain transcriptionally repressed, supporting a model in which bivalent chromatin raises the enhancer activation threshold to preserve developmental competence while preventing inappropriate lineage-gene activation.
We next applied CoCUT&Tag to generate paired profiles of H3K27me3, H2AK119Ub and H3K4me2 in primary bone marrow from healthy donors and patients with MDS. Across the MDS cohort, granulocyte-monocyte progenitors were consistently depleted. In addition, most patients exhibited an expansion of hematopoietic stem/multipotent progenitor cells and megakaryocyte-erythroid progenitors and a reduction in the number of B-cells. We also identified patient-specific cell populations associated with short-term survival that displayed widespread chromatin alterations, suggesting these populations may represent transformed disease states.
Within the HSC/MPP compartment, ASXL1-mutant cells exhibited distinct H3K27me3 and H2AK119Ub chromatin landscapes from healthy donors and other MDS patients. Simultaneous H3K4me2 profiling provided an internal reference for chromatin activation, distinguishing complete active-to-repressed transitions from selective redistribution of PRC1- or PRC2-associated repression. These changes fell into three recurrent regulatory modules. First, ASXL1-associated HSC/MPP states displayed extensive alterations of stem-cell self-renewal and developmental transcription-factor networks, including H3K27me3-specific reductions across the HOXA locus and at LMO1 and LMO2, together with complete active-to-repressed transitions at HOXB5, HOXB6, and NKX2-3, marked by loss of H3K4me2 and coordinated gain of H3K27me3 and H2AK119Ub. Second, RNA-processing pathways were broadly affected. HNRNPLL underwent the same complete active-to-repressed transition, while numerous spliceosome and RNA-processing genes exhibited mark-specific Polycomb redistribution. Third, immune and antigen-presentation pathways acquired increased Polycomb repression, including LILR and SIGLEC receptors, complement components, and interferon-response genes. In a subset of ASXL1-mutant patients, this program extended across the MHC class II locus, with coordinated enrichment of H3K27me3 and H2AK119Ub at HLA-DQA2 and HLA-DQB2, together with broader H3K27me3 enrichment across additional MHC class II genes.
Together, these findings demonstrate that ASXL1 mutation selectively uncouples PRC1- and PRC2-associated repression across stem-cell self-renewal, RNA-processing, and immune-regulatory networks within disease-associated HSC/MPP populations. More broadly, CoCUT&Tag directly resolves linked chromatin states in individual cells, providing a general strategy for defining combinatorial chromatin regulation during normal hematopoiesis and human disease.
DISCLOSURES
Derek H. Janssens, PhD: No relevant conflicts of interest to declare.